SurModics Performance
| SRDXDelisted Stock | USD 42.98 0.00 0.00% |
SurModics holds a performance score of 14 on a scale of zero to a hundred. The entity has a beta of -0.21, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning SurModics are expected to decrease at a much lower rate. During the bear market, SurModics is likely to outperform the market. Use SurModics sortino ratio, semi variance, as well as the relationship between the Semi Variance and day typical price , to analyze future returns on SurModics.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in SurModics are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain fundamental indicators, SurModics showed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 41.4 M | |
| Total Cashflows From Investing Activities | -2.9 M |
SurModics |
SurModics Relative Risk vs. Return Landscape
If you would invest 2,799 in SurModics on October 17, 2025 and sell it today you would earn a total of 1,499 from holding SurModics or generate 53.55% return on investment over 90 days. SurModics is currently generating 1.6958% in daily expected returns and assumes 9.029% risk (volatility on return distribution) over the 90 days horizon. In different words, 81% of stocks are less volatile than SurModics, and 66% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
SurModics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for SurModics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as SurModics, and traders can use it to determine the average amount a SurModics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1878
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | SRDX | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average SurModics is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of SurModics by adding it to a well-diversified portfolio.
SurModics Fundamentals Growth
SurModics Stock prices reflect investors' perceptions of the future prospects and financial health of SurModics, and SurModics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on SurModics Stock performance.
| Return On Equity | -0.15 | |||
| Return On Asset | -0.0052 | |||
| Profit Margin | (0.15) % | |||
| Operating Margin | 0 % | |||
| Current Valuation | 614.37 M | |||
| Shares Outstanding | 14.3 M | |||
| Price To Earning | 69.21 X | |||
| Price To Book | 5.52 X | |||
| Price To Sales | 5.09 X | |||
| Revenue | 126.08 M | |||
| EBITDA | 4.73 M | |||
| Cash And Equivalents | 22.09 M | |||
| Cash Per Share | 1.58 X | |||
| Total Debt | 33.24 M | |||
| Debt To Equity | 0.12 % | |||
| Book Value Per Share | 7.79 X | |||
| Cash Flow From Operations | 248 K | |||
| Earnings Per Share | (1.24) X | |||
| Total Asset | 178.56 M | |||
| Retained Earnings | 75.71 M | |||
| Current Asset | 58.56 M | |||
| Current Liabilities | 10.13 M | |||
About SurModics Performance
Evaluating SurModics' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if SurModics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if SurModics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota. Surmodics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 389 people.Things to note about SurModics performance evaluation
Checking the ongoing alerts about SurModics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for SurModics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| SurModics is not yet fully synchronised with the market data | |
| SurModics is way too risky over 90 days horizon | |
| SurModics appears to be risky and price may revert if volatility continues | |
| SurModics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 126.08 M. Net Loss for the year was (11.54 M) with profit before overhead, payroll, taxes, and interest of 92.07 M. | |
| Over 87.0% of the company shares are owned by institutional investors |
- Analyzing SurModics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether SurModics' stock is overvalued or undervalued compared to its peers.
- Examining SurModics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating SurModics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of SurModics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of SurModics' stock. These opinions can provide insight into SurModics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in SurModics Stock
If you are still planning to invest in SurModics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SurModics' history and understand the potential risks before investing.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |